Review our litigation support experience in regulatory affairs associated product liability & drug development/medical device product IP infringement cases

  • Home
  • Regulatory Affairs
    • RA Strategy & Submissions
    • RA Example Presentations
    • RA Peer Reviewed Pubs
  • Litigation Support
  • Recent Support Examples
  • Market Access
    • MA Strategy & Submissions
    • MA Example Presentations
    • MA White Papers
  • Pricing
    • Pricing Strategy
    • Market Research
  • Events
  • About Us
  • Contact Us
  • More
    • Home
    • Regulatory Affairs
      • RA Strategy & Submissions
      • RA Example Presentations
      • RA Peer Reviewed Pubs
    • Litigation Support
    • Recent Support Examples
    • Market Access
      • MA Strategy & Submissions
      • MA Example Presentations
      • MA White Papers
    • Pricing
      • Pricing Strategy
      • Market Research
    • Events
    • About Us
    • Contact Us
  • Sign In
  • Create Account

  • Bookings
  • My Account
  • Signed in as:

  • filler@godaddy.com


  • Bookings
  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • Regulatory Affairs
    • RA Strategy & Submissions
    • RA Example Presentations
    • RA Peer Reviewed Pubs
  • Litigation Support
  • Recent Support Examples
  • Market Access
    • MA Strategy & Submissions
    • MA Example Presentations
    • MA White Papers
  • Pricing
    • Pricing Strategy
    • Market Research
  • Events
  • About Us
  • Contact Us

Account


  • Bookings
  • My Account
  • Sign out


  • Sign In
  • Bookings
  • My Account

Reimbursement Strategy & Submissions

tJûn17 Life Sciences Advisors Market Access Support With Reimbursement

Developing an understanding of today’s global reimbursement paradigms can
be a daunting undertaking. Not only is it critical to understand payer coverage,
coding and payment mechanisms, but the converging nature of these variables
with global regulatory requirements can make this task overwhelmingly complex
to many medical technology companies. Moreover, manufacturers that wish to
commercialize innovative new technologies have a substantially more difficult
time communicating the value of their product(s) to reimbursement organizations.
tJûn17 Life Sciences is exceptionally experienced in this area, and has worked
with dozens of companies to successfully navigate global reimbursement system
pathways. Our company has relationships with hundreds of payers across
the globe, and can utilize these relationships to support the  development and execution of successful reimbursement strategies that  optimize payment levels.



Value Dossier Submissions Examples to Public & Private Payers


  • An operative hysteroscopy system for minimally invasive resection of intrauterine fibroids and polyps
  • An RF based intradiscal annulopasty system for use in the spine
  • Single and multi-use synovial fluid replacement therapies for treatment of osteoarthritis
  • A novel biopolymer based material for use in cartilage repair in the knee and hip
  • An in vitro diagnostic kit for optimization of 5-FU therapy for colorectal cancer
  • An interventional radiology system for visualization and treatment of liver oncology
  • A visually based diagnostic system for detection of breast oncology


Additional tJûn17 Life Sciences Advising Support



  • Global cost and comparative effectiveness evaluations for new technologies and products
  • Development and implementation of global health and economic outcomes strategies
  • Design and implementation of online and on-ground training courses in cost and comparative study design and execution
  • Review and assessment of Health Technology Assessments (HTA’s) and  their potential impact on technology and product commercialization
  • Incorporation of cost and comparative effectiveness and HTA study results into reimbursement dossiers

Learn More

A properly developed life science product reimbursement strategy must, by necessity, include an assessment and operational alignment with its regulatory strategy. Innovation, in and of itself, is not enough for successful commercialization in any geographic area.

Find out more
  • Home

tJun17 Life Science Advisors, LLC

175 Woodland Mead, South Hamilton, Massachusetts 01982, United States

(781) 640-0553

Copyright © 2022 tJun17 Life Science Advisors, LLC - All Rights Reserved.

This website uses cookies

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept